Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review

[1] Al-Khatib SM(2018)2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Heart Rhythm 15 e73-e189

[2] Stevenson WG(2005)State of disparities in cardiovascular health in the United States Circulation 111 1233-1241

[3] Ackerman MJ(2022)Racial disparities in cardiovascular risk and cardiovascular care in women Curr Cardiol Rep 24 1197-1208

[4] Bryant WJ(2021)Disparities in cardiovascular medicine Circulation 143 2319-2320

[5] Callans DJ(2005)Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure N Engl J Med 352 225-237

[6] Curtis AB(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877-883

[7] Mensah GA(2004)Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction N Engl J Med 351 2481-2488

[8] Mokdad AH(2007)Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996–2001 J Natl Med Assoc 99 201-929

[9] Ford ES(2007)Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35% Am J Cardiol 100 924-25

[10] Greenlund KJ(2008)Disparity in utilization of implantable cardioverter-defibrillators in treatment of heart failure based on sex and race Womens Health 4 23-1215

[1] Al-Khatib SM(2018)2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Heart Rhythm 15 e73-e189

[2] Stevenson WG(2005)State of disparities in cardiovascular health in the United States Circulation 111 1233-1241

[3] Ackerman MJ(2022)Racial disparities in cardiovascular risk and cardiovascular care in women Curr Cardiol Rep 24 1197-1208

[4] Bryant WJ(2021)Disparities in cardiovascular medicine Circulation 143 2319-2320

[5] Callans DJ(2005)Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure N Engl J Med 352 225-237

[6] Curtis AB(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 877-883

[7] Mensah GA(2004)Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction N Engl J Med 351 2481-2488

[8] Mokdad AH(2007)Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996–2001 J Natl Med Assoc 99 201-929

[9] Ford ES(2007)Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35% Am J Cardiol 100 924-25

[10] Greenlund KJ(2008)Disparity in utilization of implantable cardioverter-defibrillators in treatment of heart failure based on sex and race Womens Health 4 23-1215